Nature medicine

• 

  Año 2005, Número 5

  • Scientists seek simple remedies to cloning conundrums

    pág. 459

    

  • US policy keeps drugs out of reach in clinical trials abroad

    pág. 460

    

  • Indian law could choke cheap drug supply

    pág. 460

    

  • Scientists charged with choosing publication over public health

    pág. 461

    

  • Bugs gain vital ground in their battle against drugs

    pág. 461

    

  • Personalized medicine prompts push to redesign clinical trials

    pág. 462

    

  • Sports law could even the score for women in science

    pág. 462

    

  • Curious Minds: How a Child Becomes a Scientist John Brockman

    E. F. Keller

    págs. 467-468

    

  • HIV swiftly guts the immune system

    A. A. Lackner, R. S. Veazey

    págs. 469-470

    

  • Lipid let loose in pulmonary emphysema

    J. A. Elias

    pág. 471

    

  • Killing pain, killing neurons?

    T. Wyss-Coray

    págs. 472-473

    

  • DNA instability and the brain: survival of the `fittest'

    C. Barlow, K. Treuner

    pág. 474

    

  • Do-all receptor takes on coagulation, inflammation

    C. Esmon

    págs. 475-476

    

  • Radiation's outer limits

    R. Weichselbaum

    pág. 477

    

  • Muscle disease: a giant feels the strain

    L. Tskhovrebova

    págs. 478-479

    

  • Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis

    R. L. DeWitty, I. Poola, J. J. Marshalleck

    págs. 481-483

    

  • ATM regulates target switching to escalating doses of radiation in the intestines

    H.-J. Ch ang

    págs. 484-490

    

  • Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice

    I. Petrache, V. Natarajan

    págs. 491-498

    

  • Lactadherin promotes VEGF-dependent neovascularization

    J.-S. Silvestre

    págs. 499-506

    

  • PI 3-kinase p110beta: a new target for antithrombotic therapy

    S. P. Jackson, S. M. Schoenwaelder

    págs. 507-514

    

  • Integrin alphavbeta3 is a coreceptor for human cytomegalovirus

    S.-M. Huong, X. Wang, D. Y. Huang, E.-S. Huang

    págs. 515-521

    

  • Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus

    T. Oliphant

    págs. 522-530

    

  • Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract

    W. Cheng

    págs. 531-537

    

  • An essential function for NBS1 in the prevention of ataxia and cerebellar defects

    P.-O. Frappart

    págs. 538-544

    

  • Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production

    J. L. Eriksen, M. P. Murphy, T. Kukar

    págs. 545-550

    

  • A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

    M. H. Tuszynski

    págs. 551-555

    

  • Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo

    C. A. Lemere, G. M. Shankar, W. K. Cullen, D. M. Walsh, I. Klyubin

    págs. 556-561

    

  • Thromboxane A~2 and prostaglandin F~2~a~l~p~h~a mediate inflammatory tachycardia

    K. Takayama

    págs. 562-566

    

  • Deletion of Gab1 in the liver leads to enhanced glucose tolerance and improved hepatic insulin action

    E. A. Bard-Chapeau

    págs. 567-571

    

  • In vivo imaging of axonal degeneration and regeneration in the injured spinal cord

    M. Kerschensteiner

    págs. 572-577